Information:
Error:
ID
34602
Description
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION); ODM derived from: https://clinicaltrials.gov/show/NCT01541956
Link
https://clinicaltrials.gov/show/NCT01541956
Keywords
Versions (1)
- 1/19/19 1/19/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 19, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT01541956
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01541956
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
chinese t2d patients who are inadequate controlled (6.5 %< hba1c ≤9%) by metformin (≥750mg/d but ≤1000mg/d, ≥12 weeks),
boolean
ID.2
Item
type 1 diabetes and secondary diabetes
boolean
ID.3
Item
acute metabolic diabetic complications within the past 3 months.
boolean
ID.4
Item
acute infections which may influence glucose level.
boolean
ID.5
Item
evidence of significant chronic diabetic complications,
boolean
ID.6
Item
clinically significant renal impairment and hepatic impairment patients, including history of cirrhosis or chronic hepatitis,
boolean
ID.7
Item
fpg > 270 mg/dl (15 mmol/l)
boolean
ID.8
Item
any of the following disease within the past 6 months: myocardial infarction (mi); coronary artery bypass surgery or percutaneous coronary intervention; unstable angina or stroke; congestive heart failure (chf)
boolean
ID.9
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean